Conquering Diseases

Study Of Immunotherapy Alone Or In Combination With Chemotherapy For Advanced Nonsquamous Non-Small Cell Lung Cancer

Description

Non-squamous non-small cell lung cancer patients whose cancer has been tested to be PD-L1 positive (a kind of tumor marker) sought for study comparing two usual approaches to treatment.

Overview

Patients with non-squamous non-small cell lung cancer that has spread outside their lungs are usually treated with either immunotherapy drugs or a combination of immunotherapy and chemotherapy drugs. We are comparing these two different treatments for PD-L1 positive non-squamous non-small cell lung cancer to see if one of these two usual approaches is better or worse than the other.

What we're hoping for

We hope to understand how best to treat PD-L1 positive non-squamous non-small cell lung cancer in patients whose cancer has spread outside their lungs.

Additional Information

ClinicalTrials.gov Identifier: NCT03793179

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

Cindy  Huynh

Cindy.Huynh@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989